Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04778592 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain
A Phase 2 study of Lumbosacral Radiculopathy, sponsored by Eliem Therapeutics (UK).
- Completed
- Registry status
- Phase 2
- Development phase
- 149
- Enrollment target
- 20
- Study locations
NCT04778592 is a Phase 2 study of Lumbosacral Radiculopathy that has completed, run by Eliem Therapeutics (UK). The registered enrollment target is 149 participants, above the 30-participant average among 3 other Lumbosacral Radiculopathy trials with a reported enrollment target (397% higher). The trial reports 20 study locations across 15 states.
The verdict
NCT04778592, a Phase 2 study of Lumbosacral Radiculopathy, has completed, sponsored by Eliem Therapeutics (UK).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 149 participants
- Enrollment target
- 20
- Study locations
Study Summary
Efficacy and Safety of ETX 018810 in Subjects with Lumbosacral Radicular Pain
Conditions Studied
Interventions
- DRUG Placebo
- DRUG ETX-018810
Study Locations (20)
Florida
- Charter Research - Lady Lake
- Cordova Research Institute - Miami
- Advanced Medical Research Institute - Miami
- Coral Research Clinic Corp - Miami
Georgia
- Drug Studies America - Marietta
- Better Health Clinical Research - Newnan
New York
- Drug Trials America - Hartsdale
- University of Rochester Translational Pain Research - Rochester
Alabama
- Delta Clinical Research - Mobile
Arizona
- Arizona Research Center - Phoenix
Colorado
- DBPS Research LLC - Greenwood Village
Idaho
- Injury Care Research - Boise
Illinois
- Chicago Anesthesia Research Specialist - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2021-01-19 |
| Est. Completion | 2022-05-25 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04778592
The ClinicalTrials.gov registry entry for NCT04778592 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 30-participant average among 3 other Lumbosacral Radiculopathy trials with a reported enrollment target (397% higher). The listed sponsor is Eliem Therapeutics (UK), which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lumbosacral Radiculopathy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04778592 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Florida, Georgia, New York.
Frequently Asked Questions
What is clinical trial NCT04778592 about?
NCT04778592 is a clinical study titled "Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain". Efficacy and Safety of ETX 018810 in Subjects with Lumbosacral Radicular Pain
What is the current status of trial NCT04778592?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 149 participants. The study started on 2021-01-19. Estimated completion is 2022-05-25.
What conditions does trial NCT04778592 study?
This clinical trial studies the following conditions: Lumbosacral Radiculopathy.
What interventions are being tested in trial NCT04778592?
The interventions under investigation include: Placebo (DRUG), ETX-018810 (DRUG).
Who is sponsoring clinical trial NCT04778592?
This trial is sponsored by Eliem Therapeutics (UK), which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04778592 being conducted?
This trial has 20 study locations across Alabama, Arizona, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lumbosacral Radiculopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy
COMPLETED · Phase 2
-
A Multicomponent Intervention for Patients With Lumbosacral Radiculopathy: Move-MORE
RECRUITING · NA
-
A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Study
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.